Kymera Perspectives

Hear from our team on recent breakthroughs, scientific and clinical advancements, company culture, and our ongoing work to develop new medicines at Kymera.

WICTB Aimee Perspectives Preview Square
October 6, 2026

When Aimee Mishkin joined Kymera as our first regulatory hire, she had the rare opportunity to build a function from scratch. Six years later, she reflects on helping chart new development paths for our first-in-class oral degrader medicines, the team she’s built, and why new perspectives will help amplify innovation as the company grows.

Featured

September 10, 2026
What I Came to Build: Sagar Agarwal
August 17, 2026
Earning the Right to Grow
Kymera Founders Nello Mainolfi & Bruce Booth
December 16, 2025
From Target Selection to POC in Patients: Completing the Initial Human Translation of STAT6 Degradation
Nello Mainolfi, PhD, Founder, President and CEO
Icon_In-the-News
Discover Our Latest Milestones

Stay ahead with the latest news from Kymera. Our Press Releases provide insights into our recent achievements and future endeavors.